2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
24
Endocrine
5
Genitourinary
2
Conditions
Prostatic Neoplasms
6268
Carcinoma, Renal Cell
1913
Urinary Bladder Neoplasms
1670
Kidney Neoplasms
930
Breast Neoplasms
793
Neoplasms
788
Carcinoma, Transitional Cell
594
Carcinoma, Non-Small-Cell Lung
524
Neoplasm Metastasis
510
Melanoma
485
Ovarian Neoplasms
468
Colorectal Neoplasms
454
Lung Neoplasms
435
Pancreatic Neoplasms
325
Testicular Neoplasms
290
Stomach Neoplasms
274
Sarcoma
267
Uterine Cervical Neoplasms
264
Non-Muscle Invasive Bladder Neoplasms
263
Head and Neck Neoplasms
241
Colonic Neoplasms
217
Esophageal Neoplasms
203
Squamous Cell Carcinoma of Head and Neck
202
Carcinoma, Hepatocellular
197
Wilms Tumor
196
Endometrial Neoplasms
189
Recurrence
162
Neuroblastoma
148
Urologic Neoplasms
147
Small Cell Lung Carcinoma
146
Interventions
etelcalcetide hydrochloride
1
Cinacalcet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hyperparathyroidism
×
Genitourinary
×
Clear all
NCT03123406
2024-04-29
ACTIVE
Kyowa Kirin Co., Ltd.
Phase 4
Completed
750 enrolled
NCT03960437
2023-09-21
Parsabiv-MBD
Columbia University
Phase 2
Completed
22 enrolled
14 charts